Status:
NOT_YET_RECRUITING
Evaluation of a Dietary Supplement Containing Melissa Officinalis Formulated in Phospholipids on Mood Well-being and Cortisol Modulation
Lead Sponsor:
Azienda di Servizi alla Persona di Pavia
Conditions:
Stress
Mood Disorders
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This is a randomized, double-blind, placebo-controlled pilot study designed to evaluate the effect of an oral nutritional supplement containing Melissa officinalis formulated in phospholipids on mood ...
Eligibility Criteria
Inclusion
- Age between 18 and 65 years
- Healthy volunteers as assessed by medical history and physical examination
- Willingness to comply with the study procedures
Exclusion
- Current use of medications or supplements that may affect mood or cortisol levels
- Known allergy or sensitivity to Melissa officinalis or phospholipids
- History of psychiatric disorders (e.g., major depression, anxiety disorders)
- Significant comorbidities (e.g., cardiovascular, hepatic, renal diseases)
- Pregnant or breastfeeding women
- Participation in another clinical trial in the past 30 days
Key Trial Info
Start Date :
June 15 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06942897
Start Date
June 15 2026
End Date
September 15 2026
Last Update
November 25 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.